Answer
Belimumab (Benlysta) has not been studied for effects on driving or using machines, and none detrimental are predicted from its pharmacology, but the patient's clinical status and Benlysta's adverse reaction profile should be considered when assessing tasks requiring judgement, motor or cognitive skills.
Sources for this answer
- Benlysta 120 mg and 400 mg powder for concentrate for solution for infusionGlaxoSmithKline UK · emc · SmPC §4.7 Effects on ability to drive and use machines · Version 35Document updated
Sources checked